About
Senseera offers an AI-driven Chromatin Liquid Biopsy platform that maps gene expression from blood, providing cell-type and state insights for diagnostics and disease monitoring. Their patented technology captures active chromatin to generate high-resolution gene expression biomarkers, empowering drug development and enabling precise diagnosis and monitoring of conditions like liver disease. The platform serves the pharmaceutical industry by enhancing target selection, trial design, and understanding drug biology.
Key facts
At-a-glance profile data
- Website
- senseerahealth.com
- Headquarters
- San Diego, United States
- Founded
- 2020
- Employees
- 20
- Total funding
- $7M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 7 Jan 2025 | Seed | $7M | Lightspeed Venture Partners |
Tech stack
Detected on senseerahealth.com, last scanned 11 Sept 2026. Run your own scan
- Compliance
- GDPR, CCPA
- Frontend
- jQuery
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Google Workspace
Frequently asked
How much funding has Senseera raised?
Senseera has raised a total of $7M in funding. The most recent round on record is Seed.
How many employees does Senseera have?
Senseera has approximately 20 people on record.